Mesenchymal stem cell-derived exosome (MSC-Exo)

Mesenchymal stem cell-derived exosomes (MSC-Exos) are nano-sized extracellular vesicles, typically 30 to 150 nanometers in diameter, that are secreted by mesenchymal stem cells to facilitate intercellular communication [1, 4]. They function by transferring a rich cargo of bioactive molecules, including microRNAs, messenger RNAs, proteins, and lipids, which directly influence the physiological state of recipient cells [8, 11]. MSC-Exos are increasingly recognized as a potent cell-free therapeutic modality, offering regenerative and immunomodulatory benefits similar to their parent cells while minimizing risks associated with whole-cell transplantation, such as low survival or uncontrolled differentiation [3, 9, 18]. In various disease models, these vesicles have demonstrated efficacy in promoting tissue repair, suppressing inflammation, and inhibiting apoptosis across conditions like osteoarthritis, myocardial infarction, and neurodegenerative diseases [7, 10, 14, 19]. They interact with the immune system by modulating macrophage polarization from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype [8, 21]. Furthermore, MSC-Exos are being developed as specialized drug delivery vehicles, capable of being engineered to carry chemotherapeutic agents or genetic material to specific tissues [11, 22]. Despite their therapeutic promise, significant challenges remain, including the need for standardized isolation methods and concerns regarding their potential to promote tumor-related angiogenesis [5, 16].

Other names

MSC-derived extracellular vesicleMSC-EVMesenchymal stem cell secretomeMSC-derived nano-vesicleMSC-exo

Mesenchymal stem cell-derived exosomes operate through paracrine signaling, delivering a variety of bioactive cargo—such as microRNAs (miRNAs), messenger RNAs (mRNAs), and proteins—directly to recipient cells [1, 8]. Once internalized, these components modulate key intracellular signaling pathways, including the Wnt/β-catenin and PI3K/Akt/mTOR pathways, to promote cell proliferation, inhibit apoptosis, and enhance tissue regeneration [10, 14, 21]. They also exert immunomodulatory effects by inducing the polarization of macrophages from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype and suppressing the activation of T cells [8, 10, 21]. Furthermore, their ability to stimulate angiogenesis by increasing factors like VEGF contributes to their therapeutic role in healing and repair [1, 18, 20].